Atlas Trials

The Efficacy of TROP2-ADC in Advanced Extrapulmonary High-Grade Neuroendocrine Neoplasms Failure of Standard Therapy

Clinical trial NCT07077564 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07077564
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Neoplasms (Tumours)
Start date
2025-07-20
Primary completion
2027-07-20
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.